Apeiron Biologics' Grant

Apeiron Biologics raised a round of funding on March 22, 2018. Investors include FFG.

Apeiron is a private biotech company based in Vienna, Austria, engaged in innovative projects in immuno-oncology. Recently the most advanced project (immunotherapy of neuroblastoma) was granted market…

Articles about Apeiron Biologics' Grant: